Boreal Genomics said this week that it has secured a Series B financing round totaling $6.9 million to accelerate the commercialization of its Aurora nucleic acid purification and concentration platform and to develop new biomolecular separation methods.

Arch Venture Partners, Kearny Venture Partners, and GrowthWorks Capital led the financing round. InQTel also participated in the financing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.